Therefore, the therapeutic potential of MALT1 inhibition in autoimmune disease and cancer has raised a lot of interest and led to the development of potent small compound MALT1 inhibitors (Bardet et al., 2018). The gene discussed is MALT1; the disease is autoimmune disease.